For the first layer of predictive model, a biomarker panel consisting of 22 predictive marker candidates was established to distinguish healthy controls from patients with T2DM or diabetic kidney disease, including malonic acid, pep_1047.36_COL1A1 and so on. Here, COL1A1 is linked to type 2 diabetes mellitus.